?rel=0" Segment Description: Ben Berkhout, MD, PhD, discusses his work on the development of a novel curative strategy for HIV-1 infected individuals.
Interview transcript (modified slightly for readability):
Ben Berkhout, MD, PhD: We work on the development of a novel curative strategy for HIV-1 infected individuals. As you know, we have many drugs that we can use to block the virus replication and these drugs are wonderful, they have saved many lives.
But what we are trying to establish is a new therapy that will be a 1 shot therapy, with a long-term curative effect. Because all of these drugs are wonderful, but you have to take them every day of your life, so that’s what we want to change, and this is based on the CRISPR-cas technology.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512